Continuation of EGFR/ALK inhibition after local therapy of oligoprogressive disease in EGFR mutant (Mt) and ALK plus non-small cell lung cancer (NSCLC) Conference Paper uri icon


  • Weickhardt, Andrew James
  • Scheier, Benjamin
  • Burke, Joseph Malachy
  • Gan, Gregory
  • Doebele, Robert Charles
  • Bunn, Paul A
  • Gaspar, Laurie E
  • Kavanagh, Brian D
  • Camidge, D Ross

publication date

  • May 20, 2012